Announcements Trials
Browse Landscape

Phase

Phase 1/2 5Phase 2 3Phase 1 3Phase NA 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Plasma cell 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Lymphoma 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia 13Lymphoma, Non-Hodgkin 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Myeloid, Acute 7Myelodysplastic Syndromes 6Leukemia, Lymphocytic, Chronic, B-Cell 6Sarcoma 5Neuroblastoma 5Neoplasms 5Lymphoma, Mantle-Cell 5Burkitt Lymphoma 5Lymphoma, Large B-Cell, Diffuse 4Hodgkin Disease 4Hematologic Neoplasms 3Hematologic Diseases 3Breast Neoplasms 3Testicular Neoplasms 2Teratoma 2Retinoblastoma 2Preleukemia 2Precancerous Conditions 2Neoplasms by Histologic Type 2Myeloproliferative Disorders 2Lymphoproliferative Disorders 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphatic Diseases 2Leukemia, Myelomonocytic, Juvenile 2

Interventions

Cyclophosphamide 41fludarabine 35Tacrolimus 28Mycophenolic Acid 27Whole-Body Irradiation 25Busulfan 24fludarabine phosphate 21Melphalan 19thymoglobulin 16Antilymphocyte Serum 16Methotrexate 13Thiotepa 12Stem Cell Transplantation 9Rituximab 9Granulocyte Colony-Stimulating Factor 9Filgrastim 8Cyclosporine 8trametinib 7Sirolimus 7Nivolumab 5ruxolitinib 4merphos 4Peripheral Blood Stem Cell Transplantation 4Cytarabine 4Cord Blood Stem Cell Transplantation 4Bendamustine Hydrochloride 4tocilizumab 3itacitinib 3fedratinib 3dabrafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Hematologic Neoplasms × Mesna × Clear all
NCT05579769 2025-10-02

Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.

St. Jude Children's Research Hospital

Phase 2 Terminated
3 enrolled 10 charts
Other hematologic neoplasm

Hematologic Neoplasms

NCT01010217 2020-03-25

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

M.D. Anderson Cancer Center

Phase 2 Completed
176 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02199041 2018-02-07

Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen

St. Jude Children's Research Hospital

Phase 2 Terminated
24 enrolled 17 charts
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡